MASTering the immune response: Mast cells in autoimmunity

Novartis Foundation Symposium

Volumn 271, Issue , 2005, Pages 215-225

  Gregory, Greg D ^a   Bickford, Allison ^b   Robbie Ryan, Michaela ^a   Tanzola, Mindy ^a   Brown, Melissa A ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; AUTOIMMUNITY; CELLULAR IMMUNITY; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MAST CELL; METABOLISM; MOUSE; MULTIPLE SCLEROSIS; PATHOLOGY; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; MAST CELLS; MICE; MULTIPLE SCLEROSIS; PROTO-ONCOGENE PROTEINS C-KIT; T-LYMPHOCYTES;

EID: 33745327356     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (31)

1. Ansel J, Brown JR, Payan DG, Brown MA 1993 Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150:4478-4485
2. Bebo BF Jr, Lee CH, Orr EL, Linthicum DS 1996 Mast cell-derived histamine and tumor necrosis factor: Differences between SJL/J and BALB/c inbred strains of mice. Immunol Cell Biol 74:225-230
3. Bjartmar C, Wujek JR, Trapp BD 2003 Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171
4. Cross AH, Trotter JL, Lyons J 2001 B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112:1-14
5. Erdei A, Andrasfalvy M, Peterfy H, Toth G, Pecht I 2004 Regulation of mast cell activation by complement-derived peptides. Immunol Lett 92:39-42
6. Ford ML, Evavold BD 2005 Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 35:76-85
7. d mice: their value for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathology 127:191-198
8. Gladue RP, Carroll LA, Milici AJ et al 1996 Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. J Exp Med 183:1893-1898
9. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH 2003 Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4:965-973
10. Gordon J, Burd P, Galli SJ 1990 Mast cells as a source of multifunctional cytokines. Immunol Today 11:458-464
11. Hundley TR, Gilfillan AM, Tkaczyk C et al 2004 Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104:2410-2417
12. Kuchroo VK, Anderson AC, Waldner H et al 2002 T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol 20:101-123
13. Lock C, Hermans G, Pedotti R et al 2002 Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8:500-508
14. Maldonado-Lopez R, Maliszewski C, Urbain J, Moser M 2001 Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 167:4345-4350
15. Marshall JS, McCurdy JD, Olynych T 2003 Toll-like receptor-mediated activation of mast cells: implications for allergic disease? Int Arch Allergy Immunol 132:87-97
16. MartIn-Fontecha A, Sebastiani S, Hopken UE et al 2003 Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 198:615-621
17. Neu IS, Metzger G, Zschocke J, Zelezny R, Mayatepek E 2002 Leukotrienes in patients with clinically active multiple sclerosis. Acta Neurol Scand 105:63-66
18. Nocka K, Tan JC, Chiu E et al 1990 Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J 9:1805-1813
19. Ott VL, Cambier JC, Kappler J, Marrack P, Swanson BJ 2003 Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat Immunol 4:974-981
20. Repka-Ramirez MS, Baraniuk JN 2002 Histamine in health and disease. Clin Allergy Immunol 17:1-25
21. Robbie-Ryan M, Tanzola MB, Secor VH et al 2003 Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J Immunol 170:1630-1634
22. Secor VH, Secor WE, Gutekunst CA, Brown MA 2000 Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191:813-822
23. Steinman L 1996 Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85:299-302
24. Steinman L 2001 Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J Exp Med 194:F27-F30
25. Sun D, Whitaker JN, Huang Z et al 2001 Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 166:7579-7587
26. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD 2003 Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4:982-990
27. Tanzola MB, Robbie-Ryan M, Gutekunst CA, Brown MA 2003 Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171:4385-4391
28. Theoharides TC 1990 Mast cells: the immune gate to the brain. Life Sci 46:607-617
29. Toms R, Weiner HL, Johnson D 1990 Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J Neuroimmunol 30:169-177
30. Waskow C, Paul S, Haller C, Gassman M, Rodewald H 2002 Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity 17:277-288
31. Williams CM, Galli SJ 2000 The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105:847-859